✦ LIBER ✦

Clinical maintenance response with risperidone long-acting injectable (rlai) in subjects with schizophrenia or schizoaffective disorder: A 52 weeks Italian study

✍ Scribed by A. Rossi; M.M. Bernareggi; M.G. Giustra

Book ID: 118439794
Publisher: Elsevier Science
Year: 2008
Tongue: French
Weight: 60 KB
Volume: 23
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2008.01.962

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Remission in schizophrenia: 1 year Itali

Remission in schizophrenia: 1 year Italian study with risperidone long-acting injectable (RLAI) in subjects with schizophrenia or schizoaffective disorder

✍ A. Rossi; M.M. Bernareggi; M.G. Giustra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 42 KB

Subjective attitude to risperidone long-

Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder

✍ A. Rossi; M.M. Bernareggi; M.G. Giustra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 42 KB

Remission in schizophrenia: one-year Ita

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder

✍ Alessandro Rossi; Anna Bagalà; Vincenzo Del Curatolo; Francesco Scapati; Micaela 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac